Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Marshall

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Scandinavian Journal of Work, Environment & Health|June 13, 2018
Labor market and health trajectories during periods of economic recession and expansion in the United States, 1988‒2011Jonathan K Fan, Benjamin C Amick, Lindsey Richardson, et al.
International Journal of Molecular Sciences|July 29, 2023
<i>SF3B1</i> Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic LeukemiaErhan Aptullahoglu, Jonathan P Wallis, Helen Marr, et al.
Bioinformatics (Oxford, England)|September 21, 2007
A semantic web approach applied to integrative bioinformatics experimentation: a biological use case with genomics dataLennart J G Post, Marco Roos, M Scott Marshall, et al.
European Journal of Clinical Pharmacology|August 11, 2015
Model-based meta-analysis of the effects of non-selective and α1-selective GABAA receptor agonists in healthy volunteersYu-Peng Ren, Ru-Jia Xie, Scott Marshall, et al.
Biomedicines|July 27, 2024
RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in <i>TP53</i> Wild-Type Chronic Lymphocytic LeukemiaErhan Aptullahoglu, Sirintra Nakjang, Jonathan P Wallis, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 10, 2018
Model-Informed Drug Discovery and Development: Current Industry Good Practice and Regulatory Expectations and Future PerspectivesScott Marshall, Rajanikanth Madabushi, Efthymios Manolis, et al.
Medical Care|November 14, 2013
How much do preexisting chronic conditions contribute to age differences in health care expenditures after a work-related musculoskeletal injury?Peter M Smith, Amber Bielecky, Selahadin Ibrahim, et al.
BMC Bioinformatics|October 3, 2009
A journey to Semantic Web query federation in the life sciencesKei-Hoi Cheung, H Robert Frost, M Scott Marshall, et al.
American Journal of Industrial Medicine|January 28, 2014
Are age-related differences in the consequence of work injury greater when occupational physical demands are high?Peter Smith, Amber Bielecky, Mieke Koehoorn, et al.
Cancers|January 25, 2025
Targeting the MDM2-p53 Interaction with Siremadlin: A Promising Therapeutic Strategy for Treating <i>TP53</i> Wild-Type Chronic Lymphocytic LeukemiaErhan Aptullahoglu, Mohammed Howladar, Jonathan P Wallis, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Scandinavian Journal of Work, Environment & Health|June 13, 2018
Labor market and health trajectories during periods of economic recession and expansion in the United States, 1988‒2011Jonathan K Fan, Benjamin C Amick, Lindsey Richardson, et al.
International Journal of Molecular Sciences|July 29, 2023
<i>SF3B1</i> Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic LeukemiaErhan Aptullahoglu, Jonathan P Wallis, Helen Marr, et al.
Bioinformatics (Oxford, England)|September 21, 2007
A semantic web approach applied to integrative bioinformatics experimentation: a biological use case with genomics dataLennart J G Post, Marco Roos, M Scott Marshall, et al.
European Journal of Clinical Pharmacology|August 11, 2015
Model-based meta-analysis of the effects of non-selective and α1-selective GABAA receptor agonists in healthy volunteersYu-Peng Ren, Ru-Jia Xie, Scott Marshall, et al.
Biomedicines|July 27, 2024
RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in <i>TP53</i> Wild-Type Chronic Lymphocytic LeukemiaErhan Aptullahoglu, Sirintra Nakjang, Jonathan P Wallis, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 10, 2018
Model-Informed Drug Discovery and Development: Current Industry Good Practice and Regulatory Expectations and Future PerspectivesScott Marshall, Rajanikanth Madabushi, Efthymios Manolis, et al.
Medical Care|November 14, 2013
How much do preexisting chronic conditions contribute to age differences in health care expenditures after a work-related musculoskeletal injury?Peter M Smith, Amber Bielecky, Selahadin Ibrahim, et al.
BMC Bioinformatics|October 3, 2009
A journey to Semantic Web query federation in the life sciencesKei-Hoi Cheung, H Robert Frost, M Scott Marshall, et al.
American Journal of Industrial Medicine|January 28, 2014
Are age-related differences in the consequence of work injury greater when occupational physical demands are high?Peter Smith, Amber Bielecky, Mieke Koehoorn, et al.
Cancers|January 25, 2025
Targeting the MDM2-p53 Interaction with Siremadlin: A Promising Therapeutic Strategy for Treating <i>TP53</i> Wild-Type Chronic Lymphocytic LeukemiaErhan Aptullahoglu, Mohammed Howladar, Jonathan P Wallis, et al.
Pageof 9